Positive Late-Breaking Data for Incyte's First-in-Class mutCALR-targeted therapy INCA033989 in Essential Thrombocythemia Presented at EHA2025

Related
‘How to Train Your Dragon’ roars to No. 1 at box office with...
25 minutes ago
0
Top weekly consumer staples gainers/losers: Archer-Daniels-M...
36 minutes ago
0
Trump is said to have opposed Israeli plan to target Iran’s ...
48 minutes ago
0
What are stablecoins?
5 hours ago
0
PHL external debt hits $146.74B at end-March
5 hours ago
0
More FTAs seen as counter to Trump uncertainty
6 hours ago
0
Jobs blueprint for wholesale, retail out Monday
6 hours ago
0
Palay farmgate price falls 28.9% in May
6 hours ago
0
Trending
Popular
طلای تاریخی الفتی در قهرمانی آسیا
1 week ago
8
© FBT Company 2025. All rights are reserved